CAM
JAZZ icon

Costello Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Costello Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.92K Hold
26
– – ﹤0.01% 568
2025
Q4 		$4.42K Hold
26
– – ﹤0.01% 570
2025
Q3 		$3.43K Sell
26
-35
-57% -$4.2K ﹤0.01% 584
2025
Q2 		$6.47K Hold
61
– – ﹤0.01% 522
2025
Q1 		$7.57K Buy
61
+26
+74% +$3.39K ﹤0.01% 484
2024
Q4 		$4.31K Hold
35
– – ﹤0.01% 169
2024
Q3 		$3.9K Hold
35
– – ﹤0.01% 172
2024
Q2 		$3.74K Buy
+35
New +$3.85K ﹤0.01% 154

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Costello Asset Management's JAZZ Position: Q1 2026 in Review

Costello Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 26 shares worth $4.92K. The position accounts for ﹤0.01% of the portfolio, ranked #568.

Costello Asset Management first reported a position in JAZZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.57K in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Costello Asset Management held 26 shares of Jazz Pharmaceuticals worth $4.92K as of Q1 2026.
  • Costello Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Costello Asset Management's portfolio in Q1 2026, its #568 holding.
  • Costello Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Costello Asset Management's Jazz Pharmaceuticals position peaked at $7.57K in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Costello Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.